FDA Approves Aripiprazole as Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder
The FDA has approved ABILIFY ASIMTUFII®, a long-acting injectable medication, for treating schizophrenia and bipolar I disorder. It is administered once every two months by…
Read More
